Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Farheen Karim"'
Autor:
Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Al-Kaisi Firas, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Toby A. Eyre, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 691-699 (2022)
Objectives There are no real-world data describing infection morbidity in relapsed/refractory myeloma (RRMM) patients treated with anti-CD38 isatuximab in combination with pomalidomide and dexamethasone (IsaPomDex). In this UK-wide retrospective stud
Externí odkaz:
https://doaj.org/article/fe2def0e7bb948b8bfd8fbc77034017e
Autor:
Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e738 (2022)
Real-world data on the efficacy and tolerability of isatuximab with pomalidomide and dexamethasone (IsaPomDex) in relapsed/refractory myeloma patients have not been reported. In this UK-wide retrospective study, IsaPomDex outcomes were evaluated acro
Externí odkaz:
https://doaj.org/article/b6d57c93eb6a43d19c387a4439f8466e
Publikováno v:
Asian Journal of Transfusion Science, Vol 14, Iss 2, Pp 126-130 (2020)
Background: Transfusion-related acute lung injury (TRALI) is a rare but potentially fatal complication of blood product transfusion. It is felt worldwide that TRALI is an underrecognized and underreported entity because of lack of awareness. Aim: The
Externí odkaz:
https://doaj.org/article/80746801e4334a359fa94343acf5e764
Autor:
Nadjoua Maouche, Bhuvan Kishore, Zara Bhatti, Supratik Basu, Farheen Karim, Sharadha Sundararaman, Freya Collings, Bing Tseu, Heather Leary, Noel Ryman, Udaya Reddy, Grant D Vallance, Jaimal Kothari, Karthik Ramasamy
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0270854 (2022)
The combination of panobinostat, bortezomib and dexamethasone (PanBorDex) is available as a treatment option for relapsed refractory multiple myeloma (RRMM) based on the PANORAMA-1 trial which investigated this triplet in early relapse. In routine cl
Externí odkaz:
https://doaj.org/article/9496d85f23bf41f3b1bae63309f1bdbd
Autor:
Annabel McMillan, Supratik Basu, Kamaraj Karunanithi, Elizabeth Parkins, Edward Yan Ming Lau, Gordon Cook, Christopher Parrish, Firas Al‐Kaisi, Guy Pratt, Salim Shafeek, Stephen Jenkins, Danish Memon, Ceri Bygrave, Xenofon Papanikolaou, Tara Maisel, Sandra Hassan, Shivir Moosai, Gurvin Chander, Pallav Rakesh, Bhuvan Kishore, Farheen Karim, Georgina Talbot, Farooq Wandroo, Kwee Yong, Rakesh Popat
Publikováno v:
British Journal of Haematology. 201:682-689
Autor:
Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al‐Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Toby A. Eyre, Ceri Bygrave, Jaimal Kothari, Supratik Basu, Karthik Ramasamy
Publikováno v:
British Journal of Haematology. 201:162-167
Autor:
Bishop Gudgeon, Hannah Giles, Emma L Bishop, Taylor Fulton-Ward, Cristina Escribano-Gonzalez, Haydn Munford, Anna James-Bott, Kane Foster, Farheen Karim, Dedunu Jayawardana, Ansar Mahmood, Adam Cribbs, Daniel A. Tennant, Supratik Basu, Guy Pratt, Sarah Dimeloe
Background Multiple Myeloma (MM) is a plasma cell malignancy that develops in the bone marrow. Function of T lymphocytes is impaired in patients with MM and the bone marrow microenvironment is described as hostile for T cell activity. Precise suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d4117b2efc677d07e9764a4e9e19364
https://doi.org/10.21203/rs.3.rs-2500541/v1
https://doi.org/10.21203/rs.3.rs-2500541/v1
Autor:
Adrian M Shields, Srinivasan Venkatachalam, Salim Shafeek, Shankara Paneesha, Mark Ford, Tom Sheeran, Melanie Kelly, Iman Qureshi, Beena Salhan, Farheen Karim, Neelakshi De Silva, Jacqueline Stones, Sophie Lee, Jahanzeb Khawaja, Praveen Kumar Kaudlay, Richard Whitmill, Ghulam Nabi Kakepoto, Helen M Parry, Paul Moss, Sian E Faustini, Alex G Richter, Mark T Drayson, Supratik Basu
Publikováno v:
Clinical and Experimental Immunology
B-cell-depleting agents are among the most commonly used drugs to treat haemato-oncological and autoimmune diseases. They rapidly induce a state of peripheral B-cell aplasia with the potential to interfere with nascent vaccine responses, particularly
Autor:
Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Publikováno v:
Blood. 140:5206-5207
Publikováno v:
Asian Journal of Transfusion Science, Vol 14, Iss 2, Pp 126-130 (2020)
Asian Journal of Transfusion Science
Asian Journal of Transfusion Science
BACKGROUND: Transfusion-related acute lung injury (TRALI) is a rare but potentially fatal complication of blood product transfusion. It is felt worldwide that TRALI is an underrecognized and underreported entity because of lack of awareness. AIM: The